Sachin Lawande - Sep 22, 2023 Form 4 Insider Report for VISTEON CORP (VC)

Role
CEO & President, Director
Signature
Heidi A. Sepanik, Secretary, Visteon Corporation on behalf of Sachin S. Lawande
Stock symbol
VC
Transactions as of
Sep 22, 2023
Transactions value $
-$678,672
Form type
4
Date filed
9/25/2023, 07:07 PM
Previous filing
Jul 24, 2023
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VC Common Stock Options Exercise $1.4M +14.7K +5.98% $94.77 261K Sep 22, 2023 Direct F1, F2
transaction VC Common Stock Sale -$1.43M -10.2K -3.9% $140.32 251K Sep 22, 2023 Direct F2, F3
transaction VC Common Stock Sale -$431K -3.05K -1.21% $141.42 248K Sep 22, 2023 Direct F2, F4
transaction VC Common Stock Sale -$157K -1.1K -0.44% $142.75 247K Sep 22, 2023 Direct F2, F5
transaction VC Common Stock Sale -$57.4K -400 -0.16% $143.54 246K Sep 22, 2023 Direct F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VC Employee stock option (right to buy) Options Exercise $0 -14.7K -88.41% $0.00 1.93K Sep 22, 2023 Common Stock 14.7K $94.77 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The options will expire if not exercised prior to March 2, 2024.
F2 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 - $140.96, inclusive. The reporting person undertakes to provide to Visteon Corporation, its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.03 - $141.92, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.09 - $143.08, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.14 - $143.76, inclusive.
F7 The option is exercisable to the extent of one third of the shares optioned after one year from the date of grant, two-thirds in two years and in full after three years.